US FDA Grants Emergency Use Authorization for Malaria Drug to Treat COVID-19
[Asia Economy Reporter Minji Lee] The U.S. Food and Drug Administration (FDA) has authorized the use of chloroquine, a malaria treatment drug, and hydroxychloroquine, a similar drug, for the treatment of coronavirus disease 2019 (COVID-19).
According to Bloomberg News on the 29th (local time), the U.S. Department of Health and Human Services (HHS) announced in a statement that the FDA has granted emergency use authorization for these two drugs.
Along with this, the HHS stated that it received 30 million doses of hydroxychloroquine from Sandoz, a subsidiary of the multinational pharmaceutical company Novartis.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
- Mother of Three Gang-Raped on Bus in India... Outrage as Bus Driver Implicated
- "I Hated Myself as Much as I Craved It"... Even a Mother's Tears and Brilliant Dreams Were Shattered [ChwiYakGukga] ⑦
The department explained, “The FDA determined that emergency use authorization can be granted when there are no alternatives for a specific drug and the known potential benefits of the drug outweigh the potential risks.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.